Yellapragada Subbarow

Yellapragada Subbarow, born on January twelfth, nineteen ninety-five, was a pioneering Indian American biochemist whose groundbreaking work transformed the field of medical research. He is best known for elucidating the role of adenosine triphosphate (ATP) as a vital energy source within cells, a discovery that has had lasting implications in biochemistry and medicine.

Subbarow's contributions extended beyond ATP; he played a crucial role in the development of methotrexate, a chemotherapy drug that remains a cornerstone in cancer treatment and is also utilized for rheumatoid arthritis. His innovative spirit led to the discovery of diethylcarbamazine (DEC), the only effective medication for filariasis, showcasing his commitment to addressing pressing health challenges.

Educated at Madras Medical College, Subbarow faced personal tragedy when both his elder and younger brothers succumbed to tropical sprue within a mere eight days. This profound loss motivated him to discover folic acid, which emerged as a remedy for the condition. His career flourished primarily in the United States, where he led significant medical research efforts during World War II, despite not achieving tenure at Harvard University.

In addition to his notable discoveries, Subbarow was instrumental in the department at Lederle Laboratories, where Benjamin Minge Duggar discovered chlortetracycline in nineteen forty-five. His legacy is marked by the first synthesis of folic acid and methotrexate, cementing his status as a key figure in the advancement of biochemistry and medical research.